Literature DB >> 20825432

Osteosclerotic bone dysplasia in siblings with a Fam20C mutation.

Melanie Fradin1, C Stoetzel, J Muller, M Koob, D Christmann, C Debry, M Kohler, M Isnard, D Astruc, P Desprez, C Zorres, E Flori, H Dollfus, B Doray.   

Abstract

Raine syndrome is an autosomal recessive disorder caused by mutations in the FAM20C gene. FAM20C codes for the human homolog of DMP4, a dentin matrix protein highly expressed in odontoblasts and moderately in bone. DMP4 is probably playing a role in the mineralization process. Since the first case reported in 1989 by Raine et al. 21 cases have been published delineating a phenotype which associates dysmorphic features, cerebral calcifications, choanal atresia or stenosis and thoracic/pulmonary hypoplasia. Kan and Kozlowski suggested the name of Raine syndrome to describe this new lethal osteosclerotic bone dysplasia. All the cases described were lethal during the neonatal period except for the last two reported patients aged 8 and 11 years who presented severe mental retardation. Here we describe two sisters, with an attenuated phenotype of Raine syndrome, who present an unexpectedly normal psychomotor development at ages 4 and 1, respectively. Identification of a homozygous mutation in the FAM20C gene confirmed the Raine syndrome diagnosis, thus contributing to the expansion of the Raine syndrome phenotype. This case report also prompted us to revisit the FAM20 gene classification and allowed us to highlight the ancestral status of Fam20C.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825432     DOI: 10.1111/j.1399-0004.2010.01516.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  25 in total

Review 1.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 2.  Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Bone       Date:  2017-01-31       Impact factor: 4.398

3.  Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation.

Authors:  Bruno Ramos-Molina; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2015-03-26

Review 4.  Secreted protein kinases.

Authors:  Vincent S Tagliabracci; Lorenzo A Pinna; Jack E Dixon
Journal:  Trends Biochem Sci       Date:  2012-12-29       Impact factor: 13.807

5.  High-Phosphate Diet Improved the Skeletal Development of Fam20c-Deficient Mice.

Authors:  Hua Zhang; Lili Li; Matthew J Kesterke; Yongbo Lu; Chunlin Qin
Journal:  Cells Tissues Organs       Date:  2020-02-26       Impact factor: 2.481

6.  FAM20C regulates osteoblast behaviors and intracellular signaling pathways in a cell-autonomous manner.

Authors:  Chao Liu; Hua Zhang; Priyam Jani; Xiaofang Wang; Yongbo Lu; Nan Li; Jing Xiao; Chunlin Qin
Journal:  J Cell Physiol       Date:  2017-10-27       Impact factor: 6.384

Review 7.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

8.  Crystal structure of the Golgi casein kinase.

Authors:  Junyu Xiao; Vincent S Tagliabracci; Jianzhong Wen; Soo-A Kim; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

9.  Secreted kinase phosphorylates extracellular proteins that regulate biomineralization.

Authors:  Vincent S Tagliabracci; James L Engel; Jianzhong Wen; Sandra E Wiley; Carolyn A Worby; Lisa N Kinch; Junyu Xiao; Nick V Grishin; Jack E Dixon
Journal:  Science       Date:  2012-05-10       Impact factor: 47.728

10.  In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion.

Authors:  Qi Da; Hyojeong Han; Christian Valladolid; María Fernández; Tanvir Khatlani; Subhashree Pradhan; Jennifer Nolasco; Risë K Matsunami; David A Engler; Miguel A Cruz; K Vinod Vijayan
Journal:  J Thromb Haemost       Date:  2019-04-05       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.